June 2, 2010 โ€“ A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was released this week. The system detect blood clotting time for patients stabilized on oral anticoagulation medications such as warfarin. The CoaguSense PT/INR monitoring system was recently cleared by the U.S.

June 2, 2010 โ€“ Key research on new diagnostic uses for cardiac ultrasound will be presented at the American Society of Echocardiography (ASE) 21st Annual Scientific Sessions June 12-15, in San Diego.

Leading experts in cardiology will present and discuss the latest clinical and research developments in adult and pediatric echocardiography. Among the key presentations are:

June 2, 2010 โ€“ Heart failure patients whose treatment was guided by pulmonary artery pressures obtained through a tiny, permanent wireless implant had a 30 percent reduction in hospitalization rates at six months.

June 1, 2010 โ€“ A teleproctoring technology uses robotic technology to teach physicians about new procedures without the additional expense of travel.

June 1, 2010 โ€“ A quadripolar pacing system was recently released in Europe and offers physicians the ability to more effectively manage the ever-changing pacing needs of patients with heart failure.

June 1, 2010 โ€“ A home sleep testing technology eliminates the need for hospital sleep lab testing, instead monitoring patients in their own beds. The Nihon Kohden Nomad is a type III wearable portable recording device. It offers the ability to record 2 effort, 2 flow, snoring, body position, SpO2, heart rate and leg movements in a lightweight durable casing.

May 27, 2010 โ€“ A single catheter combining both intravascular ultrasound (IVUS) and near-infrared (NIR) spectroscopy to identify lipid-core plaques (LCP) was unveiled at EuroPRC in Paris this week. The device also was demonstrated in live patient cases.

May 27, 2010 โ€“ Positive results from CREST (Carotid Revascularization Endarterectomy vs. Stenting Trial) will be used to expand the U.S. Food and Drug Administration (FDA) indication for carotid stents.

May 27, 2010 โ€“ The first patient was recently enrolled in the ORBIT II investigational device exemption (IDE) clinical trial to evaluate the safety and effectiveness of its Diamondback 360 atherectomy system in treating calcified coronary arteries.

May 27, 2010 โ€“ One-year data presented this week at EuroPCR in Paris confirms sustained clinical outcomes with Cook Medical's drug-eluting peripheral stent, Zilver PTX.

Subscribe to
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now